457 results on '"Abe, Hiromi"'
Search Results
2. Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing
3. Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression
4. Stimulation of spinal dorsal horn β2-adrenergic receptor ameliorates neuropathic mechanical hypersensitivity through a reduction of phosphorylation of microglial p38 MAP kinase and astrocytic c-jun N-terminal kinase
5. Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice
6. Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy.
7. Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy
8. Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A
9. Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice
10. Depression: A Novel Mechanism of Antidepressant Action with a Focus on Astrocytes
11. Toward the Establishment of a Prediction System for the Personalized Treatment of Chronic Hepatitis C
12. Spinal astrocytes contribute to the circadian oscillation of glutamine synthase, cyclooxygenase-1 and clock genes in the lumbar spinal cord of mice
13. Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C
14. Effects of Hepatitis B Virus Infection on the Interferon Response in Immunodeficient Human Hepatocyte Chimeric Mice
15. IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
16. 「グローカル」教育の課題と今後の展開の可能性
17. G-to-a Hypermutation in Hepatitis B Virus (HBV) and Clinical Course of Patients with Chronic HBV Infection
18. Growth Hormone Releasing Hexapeptide: Basic Research and Clinical Application
19. Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients
20. Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy
21. G to A hypermutation of TT virus
22. ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients
23. The effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway
24. A Polymorphism in MAPKAPK3 Affects Response to Interferon Therapy for Chronic Hepatitis C
25. New insight into the enhanced effect of pegylated interferon-α
26. IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
27. Aryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production
28. Clock gene Per1 regulates the production of CCL2 and interleukin-6 through p38, JNK1 and NF-κB activation in spinal astrocytes
29. Aryl hydrocarbon receptor plays protective roles in ConA-induced hepatic injury by both suppressing IFN-γ expression and inducing IL-22
30. Vogt–Koyanagi–Harada disease in elderly Japanese patients
31. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
32. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B
33. Severe Necroinflammatory Reaction Caused by Natural Killer By Fas/FasL Interaction and Dendritic Cells in Human Hepatocyte Chimeric Mouse: 1849
34. Analysis of HCV genomes against direct-acting antiviral agents using human hepatocyte chimeric mice and ultra-deep sequencing: 1073
35. A functional SNP of DEPDC5 modulates gene transcription level through the allele-specific binding of FOXA1/2: 1020
36. Presence of serum HBV RNA predicts initial virological response in nucleoside analogue treated chronic hepatitis B patients: 470
37. Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication with targeting to HB core region: 480
38. Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse
39. Activation of transient receptor potential ankyrin 1 evokes nociception through substance P release from primary sensory neurons
40. Decreased response to social defeat stress in μ-opioid-receptor knockout mice
41. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population
42. Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo
43. Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus
44. Inverse Association of IL28B Genotype and Liver mRNA Expression of Genes Promoting or Suppressing Antiviral State
45. Common Genetic Polymorphism of ITPA Gene Affects Ribavirin-Induced Anemia and Effect of Peg-Interferon Plus Ribavirin Therapy
46. Prediction of Response to Peginterferon-Alfa-2b Plus Ribavirin Therapy in Japanese Patients Infected With Hepatitis C Virus Genotype 1b
47. HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy
48. Animal model for study of human hepatitis viruses
49. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection
50. Successful Treatment of an Entecavir-Resistant Hepatitis B Virus Variant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.